2025
SJR Q1
JCR Q1 · 5,2
24 eşleşen makale
SCIE
Dergi ayrıntısı
BioFactors
- Yayıncı
- Wiley-Blackwell
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0951643318728081
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,361
- Quartile Q1
- H-Index 125
- Atıf/yayın 5,35
- Doküman (3y) 245
- Atıf (3y) 1.543
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,2
- 5Y JIF 5,9
- JCI 0,95
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Biochemistry Q1
- Clinical Biochemistry Q1
- Medicine (miscellaneous) Q1
- Molecular Medicine Q1
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Biochemistry & Molecular Biology | Endocrinology & Metabolism
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,361 | 5,2 | 5,9 | 0,95 | Q1 | 125 |
| 2024 | Q1 | Q1 | 1,329 | 5 | 5,7 | 0,88 | Q2 | 120 |
| 2023 | Q1 | Q1 | 1,197 | 5 | 5,8 | 0,87 | Q2 | 120 |
| 2022 | Q1 | Q1 | 1,139 | 6 | 6,1 | 0,9 | Q2 | 120 |
| 2021 | Q1 | Q1 | 1,038 | 6,4 | 6,2 | 0,94 | Q2 | 120 |
| 2020 | Q1 | Q1 | 1,204 | 6,1 | 5,4 | 1,03 | Q1 | 120 |
| 2019 | Q1 | Q1 | 1,05 | 4,7 | 4,2 | 0,94 | Q2 | 120 |
| 2018 | — | Q2 | — | 3,6 | 3,9 | 0,83 | Q2 | — |
| 2017 | Q1 | Q2 | 1,227 | 3 | 4,2 | 0,69 | Q3 | 120 |
| 2016 | Q1 | Q2 | 1,398 | 3,2 | 3,4 | — | — | 120 |
| 2015 | Q1 | Q1 | 1,715 | 4,5 | 3,8 | — | — | 120 |
| 2014 | Q1 | Q1 | 1,42 | 4,6 | 4,2 | — | — | 120 |
| 2013 | Q1 | Q2 | 1,206 | 3 | 3,2 | — | — | 120 |
| 2012 | Q1 | Q2 | 1,504 | 3,1 | 3 | — | — | 120 |
| 2011 | Q1 | Q1 | 1,307 | 4,9 | 3 | — | — | 120 |
| 2010 | Q1 | Q3 | 0,931 | 2,8 | 2,4 | — | — | 120 |
| 2009 | — | Q4 | — | 0,9 | 1,5 | — | — | — |
| 2008 | — | Q4 | — | 1,2 | 1,8 | — | — | — |
| 2007 | — | Q4 | — | 1,5 | 1,7 | — | — | — |
| 2006 | — | Q4 | — | 1,1 | — | — | — | — |
| 2005 | — | Q4 | — | 1,2 | — | — | — | — |
| 2004 | — | Q4 | — | 1,3 | — | — | — | — |
| 2003 | — | Q3 | — | 1,9 | — | — | — | — |
| 2002 | — | Q3 | — | 1,8 | — | — | — | — |
| 2001 | — | Q3 | — | 1,3 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 80/328 |
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 45/198 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q2 | 70/320 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 38/193 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q2 | 64/313 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 30/186 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q2 | 60/285 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 29/145 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q2 | 64/297 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 29/146 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 64/295 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 26/146 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q2 | 69/297 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 26/143 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 111/299 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 52/145 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 137/293 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 73/142 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 113/290 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 64/138 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 63/289 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 26/133 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 60/290 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 26/128 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 130/291 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 57/124 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 124/290 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 53/122 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 58/290 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 21/122 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 144/286 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 59/116 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 249/283 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 92/105 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 225/275 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 85/93 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 202/263 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 79/92 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 217/262 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 79/93 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 208/261 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 72/89 |
| 2004 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 197/261 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 66/87 |
| 2003 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 159/261 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 51/88 |
| 2002 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 150/266 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 45/88 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 206/308 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 60/90 |